Viewing Study NCT02785250


Ignite Creation Date: 2025-12-24 @ 4:48 PM
Ignite Modification Date: 2026-01-22 @ 9:48 AM
Study NCT ID: NCT02785250
Status: UNKNOWN
Last Update Posted: 2021-06-18
First Post: 2016-05-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of DPX-Survivac Therapy in Patients With Recurrent Ovarian Cancer
Sponsor: ImmunoVaccine Technologies, Inc. (IMV Inc.)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module Annotation Module